Enveric Biosciences, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Cambridge, MA
ENVB chart
What traders are saying about $ENVB
Latest postsEnveric Biosciences, Inc. news
- Enveric Biosciences, Inc. (ENVB) Seasonal returns chart - Yahoo Finance
Yahoo Finance Singapore ·
- Enveric Biosciences, Inc. (ENVB) Seasonal returns chart
Yahoo Finance UK ·
- Enveric Biosciences Reports Favorable Brain Activity Data for Lead Psychiatric Drug Candidate
AOL.com ·
- Enveric Biosciences Reports Differentiated Brain Activity Profile for EB-003 in Preclinical qEEG Study
Yahoo Finance ·
- Enveric Biosciences (ENVB) Ticks Up 3.45% to $1.50 as Buyers Probe Resistance - Profitability Factor
https://www.dars.gov.et/ ·
- Enveric Biosciences Reports Favorable Preclinical Results for Non-Hallucinogenic Psychiatric Candidate
Yahoo Finance ·
- Enveric Biosciences Announces Positive Results from Recently Completed IND-enabling ADMET Studies
Yahoo Finance ·
- Enveric Biosciences Secures New U.S. Patent Allowance for Next-Generation, Non-Hallucinogenic Mescaline Derivatives in EVM401 Series
Yahoo Finance ·
- Enveric Biosciences to Present at H.C. Wainwright 28th Annual Global Investment Conference
Yahoo Finance ·
- Enveric Biosciences Reports Financial Results and Provides Corporate Update for Second Quarter 2026
Yahoo Finance ·
- Enveric Biosciences Reports New Preclinical Data Supporting the Non-Hallucinogenic Profile of Lead Candidate EB-003
Yahoo Finance ·
- Enveric Biosciences Welcomes Final FDA Guidance for Psychedelic Drug Development
Yahoo Finance ·
Enveric Biosciences, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Net income | $12.1M | $9.6M | $17.5M | -$18.5M |
| Diluted EPS | $-36.24 | $-228.48 | $-121.29 | $-13.00 |
| Total assets (year end) | $5.1M | $3.1M | $4.3M | $19.6M |
| Cash and equivalents (year end) | – | – | – | – |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Enveric Biosciences, Inc.
- Ticker
- ENVB (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Cambridge, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 890821
- Former names
- AMERI Holdings, Inc., SPATIALIZER AUDIO LABORATORIES INC
Frequently asked questions
What exchange is Enveric Biosciences, Inc. listed on?
Enveric Biosciences, Inc. trades on the Nasdaq under the ticker symbol ENVB.
What industry is Enveric Biosciences, Inc. in?
Enveric Biosciences, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Enveric Biosciences, Inc. headquartered?
Enveric Biosciences, Inc.'s business address on file with the SEC is in Cambridge, MA.
When does Enveric Biosciences, Inc.'s fiscal year end?
Enveric Biosciences, Inc.'s fiscal year ends on December 31.
How much revenue did Enveric Biosciences, Inc. report?
Enveric Biosciences, Inc. reported $39.9M in revenue for calendar year 2019, according to its SEC filings.